Open the GMP clinical/commercial facility in North Carolina
Delivered by the deadline
AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.
- Announced
- 10 Jan 2022
- Due
- 31 Dec 2023
- Delivered
- by 31 Dec 2023
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“100,000 square foot GMP clinical/commercial facility in NC, phased build, anticipated to be operational in 2023”
What we found
Evidence strength A What the grades mean
The company confirmed in its 2023 annual report that the 100,000 square foot manufacturing facility in North Carolina initiated cGMP operations in late 2023, meeting the stated deadline.
-
A Beam Therapeutics Inc. 10-K filed 2024-02-27
“The facility, which initiated cGMP operations in late 2023, is designed to support manufacturing for our ex vivo cell therapy programs” ✓ confirmed on the page
Market reaction: the shares moved +9.9% against the S&P 500 over the three sessions around the disclosure (26 Feb 2024 to 29 Feb 2024). What this measures
Checked 2 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Facility opening
- Indicative materiality
- High rules
- Action
- Open
- Deliverable
- GMP clinical/commercial facility
- Target
- 100,000 square foot
- Where
- North Carolina
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- High
- Specificity
- High
- Depends on
- Regulatory
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works
Are you Beam Therapeutics Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2022-BEAM-003192 · Corrections policy